The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO

被引:9
|
作者
Yazici, Ozan [1 ]
Ozdemir, Nuriye [2 ]
Duran, Ayse Ocak [3 ]
Menekse, Serkan [4 ]
Ali, Mehmet
Sendur, Nahit [2 ]
Karaca, Halit [3 ]
Goksel, Gamze [4 ]
Arpaci, Erkan [5 ]
Hacibekiroglu, Ilhan [6 ]
Bilgetekin, Irem [7 ]
Kacan, Turgut [8 ]
Ozkan, Metin [3 ]
Aksoy, Sercan [1 ,9 ]
Aksoy, Asude
Cokmert, Suna [10 ]
Uysal, Mukremin [11 ]
Elkiran, Emin Tamer [9 ]
Cicin, Irfan
Buyukberber, Suleyman [7 ]
Zengin, Nurullah [1 ]
机构
[1] Ankara Numune Training & Res Hosp, Dept Med Oncol, TR-06410 Ankara, Turkey
[2] Yildirim Beyazit Univ, Fac Med, Dept Med Oncol, TR-06800 Ankara, Turkey
[3] Erciyes Univ, Fac Med, Dept Med Oncol, TR-38030 Kayseri, Talas Melikgazi, Turkey
[4] Celal Bayar Univ, Fac Med, Dept Med Oncol, TR-45030 Uncubozkoy, Manisa, Turkey
[5] Sakarya Univ, Educ & Res Hosp, Dept Med Oncol, TR-54100 Sirinevler, Sakarya, Turkey
[6] Trakya Univ, Fac Med, Dept Med Oncol, TR-22050 Karaagac, Edirne, Turkey
[7] Gazi Univ, Fac Med, Dept Med Oncol, TR-06560 Emniyet, Ankara, Turkey
[8] Cumhuriyet Univ, Fac Med, Dept Med Oncol, TR-58140 Sivas, Imaret, Turkey
[9] Inonu Univ, Fac Med, Dept Med Oncol, TR-44000 Malatya, Centre, Turkey
[10] Izmir Kent Hosp, Dept Med Oncol, Izmir, Turkey
[11] Afyon Kocatepe Univ, Fac Med, Afyon, Turkey
关键词
advanced gastric cancer; gastrectomy; resection; survival; RENAL-CELL CARCINOMA; PALLIATIVE GASTRECTOMY; CYTOREDUCTIVE NEPHRECTOMY; PLUS FLUOROURACIL; PHASE-III; RESECTION; CISPLATIN; SURGERY; CHEMOTHERAPY; EXPERIENCE;
D O I
10.2217/fon.15.304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer patients whose gastric primary tumor was resected at time of diagnosis were compared with metastatic gastric cancer patients whose primary tumor was nonresected. Results: The median progression-free survival and OS in operated and nonoperated group were 10 versus 6, 14 versus 9 months, respectively (p < 0.001). In multivariate analysis, gastric resection of primary tumor, Eastern Cooperative Oncology Group performance status, second-line chemotherapy had a significant effect on OS (hazard ratio [HR]: 0.52 [95% CI: 0.38-0.71], HR: 0.57 [95% CI: 0.42-0.78], HR: 1.48 [1.09-2.01]; p <= 0.001, p = 0.001 and p = 0.012, respectively). Conclusion: Subpopulations of patients with metastatic gastric cancer might benefit from surgical removal of primary tumor.
引用
收藏
页码:343 / 354
页数:12
相关论文
共 50 条
  • [1] The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO (vol 12, pg 343, 2016)
    Yazici, Ozan
    Oezdemir, Nuriye
    Duran, Ayse Ocak
    Menekse, Serkan
    Sendur, Mehmet Ali
    Karaca, Halit
    Goeksel, Gamze
    Arpaci, Erkan
    Hacibekiroglu, Ilhan
    Bilgetekin, Irem
    Kacan, Turgut
    Oezkan, Metin
    Aksoy, Sercan
    Aksoy, Asude
    Cokmert, Suna
    Uysal, Muekremin
    Elkiran, Emin Tamer
    Cicin, Irfan
    Bueyuekberber, Sueleyman
    Zengin, Nurullah
    [J]. FUTURE ONCOLOGY, 2016, 12 (06) : 881 - 881
  • [2] The role of the gastrectomy on survival in metastatic gastric cancer patients: A multicenter study of Anatolian Society of Medical Oncology (ASMO)
    Yazici, Ozan
    Ozdemir, Nuriye
    Duran, Ayse Ocak
    Menekse, Serkan
    Sendur, Mehmet Ali Nahit
    Karaca, Halit
    Goksel, Gamze
    Arpaci, Erkan
    Eren, Tulay
    Hacibekiroglu, Ilhan
    Bilgetekin, Irem
    Kacan, Turgut
    Ozkan, Metin
    Aksoy, Sercan
    Aksoy, Asude
    Zengin, Nurullah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Palliative Gastrectomy improves survival in metastatic gastric cancer
    R. F. Saidi
    N. N. Hanna
    P. S. Dudrick
    [J]. Annals of Surgical Oncology, 2004, 11 : S56 - S56
  • [4] Palliative gastrectomy improves survival in metastatic gastric cancer
    Saidi, RF
    Hanna, NN
    Dudrick, PS
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S56 - S56
  • [5] SURVIVAL BENEFIT OF GASTRECTOMY ± METASTASECTOMY IN METASTATIC GASTRIC CANCER PATIENTS RECEIVING CHEMOTHERAPY
    Kim, K. H.
    Lee, K.
    Baek, S. K.
    Chang, H. J.
    Kim, Y. J.
    Park, D. J.
    Kim, J. H.
    Kim, H.
    Lee, J. S.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 231 - 231
  • [6] Survival benefit of gastrectomy ±A metastasectomy in patients with metastatic gastric cancer receiving chemotherapy
    Kim, Ki Hwan
    Lee, Keun-Wook
    Baek, Sun Kyung
    Chang, Hye Jung
    Kim, Yu Jung
    Park, Do Joong
    Kim, Jee Hyun
    Kim, Hyung-Ho
    Lee, Jong Seok
    [J]. GASTRIC CANCER, 2011, 14 (02) : 130 - 138
  • [7] Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy
    Ki Hwan Kim
    Keun-Wook Lee
    Sun Kyung Baek
    Hye Jung Chang
    Yu Jung Kim
    Do Joong Park
    Jee Hyun Kim
    Hyung-Ho Kim
    Jong Seok Lee
    [J]. Gastric Cancer, 2011, 14 : 130 - 138
  • [8] Survival benefits of gastrectomy in patients with metastatic gastric cancer: A meta-analysis
    Chen, Lifan
    Chen, Yu
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024,
  • [9] Does non-curative gastrectomy improve survival in patients with metastatic gastric cancer?
    Kokkola, Arto
    Louhimo, Johanna
    Puolakkainen, Pauli
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (02) : 193 - 196
  • [10] Effect of Perioperative Transfusion on Survival and Morbidity for Gastric Cancer Patients with Gastrectomy
    Yang, Kun
    Chen, Xin-Zu
    Zhang, Wei-Han
    Hu, Jian-Kun
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (05) : 995 - 996